Advanced search
Publication Cover
Drug Delivery Volume 25, 2018 - Issue 1
Submit an article Journal homepage
4,410
Views
75
CrossRef citations to date
0
Altmetric
Articles

Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting

Liuxiang ChuSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China; View further author information
,
Aiping WangSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China; ;State Key Laboratory of Long-Acting and Targeting Drug Delivery System, Shandong Luye Pharmaceutical Co., Ltd, Yantai, ChinaCorrespondence[email protected]
View further author information
,
Ling NiState Key Laboratory of Long-Acting and Targeting Drug Delivery System, Shandong Luye Pharmaceutical Co., Ltd, Yantai, ChinaView further author information
,
Xiuju YanSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China; View further author information
,
Yina SongSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China; View further author information
,
Mingyu ZhaoSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China; View further author information
,
Kaoxiang SunSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China; ;State Key Laboratory of Long-Acting and Targeting Drug Delivery System, Shandong Luye Pharmaceutical Co., Ltd, Yantai, ChinaCorrespondence[email protected]
View further author information
,
Hongjie MuSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China; View further author information
,
Sha LiuSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China; View further author information
,
Zimei WuSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China; ORCID Iconhttp://orcid.org/0000-0001-9777-0674View further author information
ORCID Icon &
Chunyan ZhangSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China; View further author information
 show all
Pages 1634-1641 | Received 30 May 2018, Accepted 25 Jun 2018, Published online: 03 Sep 2018

Citations (75)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Nitish Kumar, Bharat Khurana & Daisy Arora. (2023) Nose-to-brain drug delivery for the treatment of glioblastoma multiforme: nanotechnological interventions. Pharmaceutical Development and Technology 0:0, pages 1-16.
Read now
Jiefen Yang, Youfa Xu, Zhiqin Fu, Jianming Chen, Wei Fan & Xin Wu. (2023) Progress in research and development of temozolomide brain-targeted preparations: a review. Journal of Drug Targeting 31:2, pages 119-133.
Read now
Changwei Hu, Xirui Wang, Yabin Li, Xiaoyong Han, Baowen Ren & Gangfeng Yin. (2022) Targeting pituitary adenomas with folate-conjugated multiple drug decorated liposomal formulations for improved antiproliferative anticancer efficacy. Journal of Experimental Nanoscience 17:1, pages 14-33.
Read now
Yuan Gao, Rui Wang, Lixia Zhao & Anchang Liu. (2021) Natural polymeric nanocarriers in malignant glioma drug delivery and targeting. Journal of Drug Targeting 29:9, pages 960-973.
Read now
Kunho Chung, Irfan Ullah, Nahyeon Kim, Jaeyeoung Lim, Jungah Shin, Sangah C. Lee, Sangmin Jeon, Sun Hwa Kim, Priti Kumar & Sang-Kyung Lee. (2020) Intranasal delivery of cancer-targeting doxorubicin-loaded PLGA nanoparticles arrests glioblastoma growth. Journal of Drug Targeting 28:6, pages 617-626.
Read now
Amit Alexander, Mukta Agrawal, Ajaz Uddin, Sabahuddin Siddique, Ahmed M Shehata, Mahmoud A Shaker, Syed Ata Ur Rahman, Mohi Iqbal M Abdul & Mohamed A Shaker. (2019) Recent expansions of novel strategies towards the drug targeting into the brain. International Journal of Nanomedicine 14, pages 5895-5909.
Read now
Shengnan Tang, Aiping Wang, Xiuju Yan, Liuxiang Chu, Xiucheng Yang, Yina Song, Kaoxiang Sun, Xin Yu, Rongxia Liu, Zimei Wu & Peng Xue. (2019) Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson’s disease. Drug Delivery 26:1, pages 700-707.
Read now

Articles from other publishers (68)

Katarzyna Sikorska, Krzysztof Sawicki, Magdalena Czajka, Lucyna Kapka-Skrzypczak, Marcin Kruszewski & Kamil Brzóska. (2023) Adverse Effects of Non-Metallic Nanoparticles in the Central Nervous System. Materials 16:23, pages 7264.
Crossref
Rajeswara Babu MythriM.R. Aishwarya. (2023) BIOPOLYMERS AS PROMISING VEHICLES FOR DRUG DELIVERY TO THE BRAIN. Drug Metabolism Reviews, pages 1-40.
Crossref
Leming Sun, Hongmei Liu, Yanqi Ye, Yang Lei, Rehmat Islam, Sumin Tan, Rongsheng Tong, Yang-Bao Miao & Lulu Cai. (2023) Smart nanoparticles for cancer therapy. Signal Transduction and Targeted Therapy 8:1.
Crossref
Ren NanamiyaHiroyuki SuzukiMika K. KanekoYukinari Kato. (2023) Development of an Anti-EphB4 Monoclonal Antibody for Multiple Applications Against Breast Cancers. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 42:5, pages 166-177.
Crossref
Shashi Kiran Misra & Kamla Pathak. (2023) Nose-to-Brain Targeting via Nanoemulsion: Significance and Evidence. Colloids and Interfaces 7:1, pages 23.
Crossref
Shiv Bahadur & Anubhav Prakash. (2023) A Comprehensive Review on Nanomedicine: Promising Approach for Treatment of Brain Tumor through Intranasal Administration. Current Drug Targets 24:1, pages 71-88.
Crossref
Li Du, Lin Chen, Fangfang Liu, Wenya Wang & Hongyun Huang. 2023. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors 255 297 .
Namdev Dhas, Soji Neyyar, Atul Garkal, Ritu Kudarha, Jahanvi Patel, Srinivas Mutalik & Tejal Mehta. 2023. Nasal Drug Delivery. Nasal Drug Delivery 101 126 .
Muhammad Sarfraz, Sara Mousa, Ranim Al Saoud & Raimar Löbenberg. 2023. Nasal Drug Delivery. Nasal Drug Delivery 339 360 .
Tejas Girish Agnihotri, Govinda Shivaji Jadhav, Bichismita Sahu & Aakanchha Jain. (2022) Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders. Drug Delivery and Translational Research 12:12, pages 3104-3120.
Crossref
Faraz Ahmad, Ressin Varghese, Subhrajita Panda, Siva Ramamoorthy, Mohammad Y. Areeshi, Sharmila Fagoonee & Shafiul Haque. (2022) Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises. Cancers 14:21, pages 5389.
Crossref
Imran Khan, Mohammad Hassan Baig, Sadaf Mahfooz, Mohammad Azhar Imran, Mohd Imran Khan, Jae-June Dong, Jae Yong Cho & Mustafa Aziz Hatiboglu. (2022) Nanomedicine for glioblastoma: Progress and future prospects. Seminars in Cancer Biology 86, pages 172-186.
Crossref
Reena Jatyan, Prabhjeet Singh, Deepak Kumar Sahel, Y.G. Karthik, Anupama Mittal & Deepak Chitkara. (2022) Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme. Journal of Controlled Release 350, pages 494-513.
Crossref
Pratikshya Sa, Priya Singh, Fahima Dilnawaz & Sanjeeb Kumar Sahoo. (2022) Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment of CNS Disorders: Challenges and Possibilities. Current Pharmaceutical Design 28:33, pages 2742-2757.
Crossref
Siqi Wang, Yawen Yu, Aiping Wang, Xinliu Duan, Yuchen Sun, Liangxiao Wang, Liuxiang Chu, Yanan Lv, Nan Cui, Xuesong Fan, Chunjie Sha, Lixiao Xu & Kaoxiang Sun. (2022) Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration. Frontiers in Pharmacology 13.
Crossref
Pauline E. M. van Schaik, Inge S. Zuhorn & Wia Baron. (2022) Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery. International Journal of Molecular Sciences 23:15, pages 8418.
Crossref
Chad A. Caraway, Hallie Gaitsch, Elizabeth E. Wicks, Anita Kalluri, Navya Kunadi & Betty M. Tyler. (2022) Polymeric Nanoparticles in Brain Cancer Therapy: A Review of Current Approaches. Polymers 14:14, pages 2963.
Crossref
Jason Thomas Duskey, Arianna Rinaldi, Ilaria Ottonelli, Riccardo Caraffi, Chiara Alessia De Benedictis, Ann Katrin Sauer, Giovanni Tosi, Maria Angela Vandelli, Barbara Ruozi & Andreas Martin Grabrucker. (2022) Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments. Pharmaceutics 14:7, pages 1450.
Crossref
Li Qiao, Huishu Yang, Xin-xin Shao, Qiuyan Yin, Xian-Jun Fu & Qingcong Wei. (2022) Research Progress on Nanoplatforms and Nanotherapeutic Strategies in Treating Glioma. Molecular Pharmaceutics 19:7, pages 1927-1951.
Crossref
Jessyca Aparecida Paes Dutra, Marcela Tavares Luiz, Alberto Gomes Tavares Junior, Leonardo Delello Di Filippo, Suzana Gonçalves Carvalho & Marlus Chorilli. (2022) Temozolomide: An Overview of Biological Properties, Drug Delivery Nanosystems, and Analytical Methods. Current Pharmaceutical Design 28:25, pages 2073-2088.
Crossref
Tong Wang, Qian Meng, Lan Lin, Li Yang, Wenjiao Zhao & Dequn Sun. (2022) Self-assembled dehydropeptide nanocarrier as a delivery system for antitumor drug temozolomide. Bioorganic Chemistry 124, pages 105842.
Crossref
Shuai Zha, Ka‐Leung Wong & Angelo H. All. (2022) Intranasal Delivery of Functionalized Polymeric Nanomaterials to the Brain. Advanced Healthcare Materials 11:11.
Crossref
Daniel E. Morales & Shaker Mousa. (2022) Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities. Heliyon 8:5, pages e09517.
Crossref
Teresa Musumeci, Giulia Di Benedetto, Claudia Carbone, Angela Bonaccorso, Giovanni Amato, Maria Josè Lo Faro, Chiara Burgaletto, Giovanni Puglisi, Renato Bernardini & Giuseppina Cantarella. (2022) Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer’s Disease. Biomedicines 10:5, pages 985.
Crossref
Yawen Yu, Aiping Wang, Siqi Wang, Yuchen Sun, Liuxiang Chu, Lin Zhou, Xiaoyue Yang, Xincui Liu, Chunjie Sha, Kaoxiang Sun & Lixiao Xu. (2022) Efficacy of Temozolomide-Conjugated Gold Nanoparticle Photothermal Therapy of Drug-Resistant Glioblastoma and Its Mechanism Study. Molecular Pharmaceutics 19:4, pages 1219-1229.
Crossref
Shelby B Smiley, Hamideh Zarrinmayeh, Sudip K Das, Karen E Pollok, Michael W Vannier & Michael C Veronesi. (2022) Novel therapeutics and drug-delivery approaches in the modulation of glioblastoma stem cell resistance. Therapeutic Delivery 13:4, pages 249-273.
Crossref
Mireya L. Borrajo & María José Alonso. (2021) Using nanotechnology to deliver biomolecules from nose to brain — peptides, proteins, monoclonal antibodies and RNA. Drug Delivery and Translational Research 12:4, pages 862-880.
Crossref
Kouminin Kanwore, Konimpo Kanwore, Gabriel Komla Adzika, Ayanlaja Abdulrahman Abiola, Xiaoxiao Guo, Piniel Alphayo Kambey, Ying Xia & Dianshuai Gao. (2022) Cancer Metabolism: The Role of Immune Cells Epigenetic Alteration in Tumorigenesis, Progression, and Metastasis of Glioma. Frontiers in Immunology 13.
Crossref
Sabina Quader, Kazunori Kataoka & Horacio Cabral. (2022) Nanomedicine for brain cancer. Advanced Drug Delivery Reviews 182, pages 114115.
Crossref
Fatih Senturk, Soner Cakmak, Menemse Gumusderelioglu & Goknur Guler Ozturk. (2022) Hydrolytic instability and low-loading levels of temozolomide to magnetic PLGA nanoparticles remain challenging against glioblastoma therapy. Journal of Drug Delivery Science and Technology 68, pages 103101.
Crossref
J. P. Jose Merlin & Xiaogang Li. (2022) Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases. Frontiers in Genetics 12.
Crossref
Honey Goel, Vinni Kalra, Sant Kumar Verma, Sunil Kumar Dubey & Ashok Kumar Tiwary. (2022) Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies. Journal of Controlled Release 341, pages 782-811.
Crossref
Riddhi Trivedi, Sharayu Govardhane & Pravin Shende. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors 431 450 .
Ramar Thangam, Ramasamy Paulmurugan & Heemin Kang. (2021) Functionalized Nanomaterials as Tailored Theranostic Agents in Brain Imaging. Nanomaterials 12:1, pages 18.
Crossref
Sagun Parakh, Joseph Nicolazzo, Andrew M Scott & Hui Kong Gan. (2021) Antibody Drug Conjugates in Glioblastoma – Is There a Future for Them?. Frontiers in Oncology 11.
Crossref
Leonardo Delello Di Filippo, Juliana Hofstätter Azambuja, Jessyca Aparecida Paes Dutra, Marcela Tavares Luiz, Jonatas Lobato Duarte, Luiza Ribeiro Nicoleti, Sara Teresinha Olalla Saad & Marlus Chorilli. (2021) Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers. European Journal of Pharmaceutics and Biopharmaceutics 168, pages 76-89.
Crossref
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tuong Kha Vo, Nguyen-Minh-An Tran, Minh Kim Nguyen, Toi Van Vo & Giau Van Vo. (2021) Nanotechnology-based drug delivery for central nervous system disorders. Biomedicine & Pharmacotherapy 143, pages 112117.
Crossref
Vishal Sharad Chaudhari, Basveshwar Gawali, Pritam Saha, V.G.M. Naidu, Upadhyayula Suryanarayana Murty & Subham Banerjee. (2021) Quercetin and piperine enriched nanostructured lipid carriers (NLCs) to improve apoptosis in oral squamous cellular carcinoma (FaDu cells) with improved biodistribution profile. European Journal of Pharmacology 909, pages 174400.
Crossref
Hetal P. Patel, Priyanshi A. Gandhi, Priyanka S. Chaudhari, Bhargavi V. Desai, Ditixa T. Desai, Praful P. Dedhiya, Furqan A. Maulvi & Bhavin A. Vyas. (2021) Clozapine loaded nanostructured lipid carriers engineered for brain targeting via nose-to-brain delivery: Optimization and in vivo pharmacokinetic studies. Journal of Drug Delivery Science and Technology 64, pages 102533.
Crossref
P. Soma Yasaswi, Karishma Shetty & Khushwant S. Yadav. (2021) Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy. Journal of Controlled Release 336, pages 549-571.
Crossref
Marcela Tavares Luiz, Leonardo Delello Di Filippo, Larissa Bueno Tofani, Jennifer Thayanne Cavalcante de Araújo, Jessyca Aparecida Paes Dutra, Juliana Maldonado Marchetti & Marlus Chorilli. (2021) Highlights in targeted nanoparticles as a delivery strategy for glioma treatment. International Journal of Pharmaceutics 604, pages 120758.
Crossref
Hussein Akel, Ruba Ismail, Gábor Katona, Fakhara Sabir, Rita Ambrus & Ildikó Csóka. (2021) A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation. International Journal of Pharmaceutics 604, pages 120724.
Crossref
Julie Bolcaen, Shankari Nair, Cathryn Driver, Tebatso Boshomane, Thomas Ebenhan & Charlot Vandevoorde. (2021) Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. Pharmaceuticals 14:7, pages 626.
Crossref
Shelby B. Smiley, Yeonhee Yun, Pranav Ayyagari, Harlan E. Shannon, Karen E. Pollok, Michael W. Vannier, Sudip K. Das & Michael C. Veronesi. (2021) Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells. Pharmaceutical Research 38:6, pages 1067-1079.
Crossref
Hetal P. Patel, Priyanka S. Chaudhari, Priyanshi A. Gandhi, Bhargavi V. Desai, Ditixa T. Desai, Praful P. Dedhiya, Bhavin A. Vyas & Furqan A. Maulvi. (2021) Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies. International Journal of Pharmaceutics 600, pages 120474.
Crossref
Raúl Ortiz, Gloria Perazzoli, Laura Cabeza, Cristina Jiménez-Luna, Raquel Luque, Jose Prados & Consolación Melguizo. (2021) Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications. Current Neuropharmacology 19:4, pages 513-537.
Crossref
Masoumeh Bayanati, Abolfazl Ghafouri Khosroshahi, Maryam Alvandi & Mohammad Mehdi Mahboobian. (2021) Fabrication of a Thermosensitive In Situ Gel Nanoemulsion for Nose to Brain Delivery of Temozolomide. Journal of Nanomaterials 2021, pages 1-11.
Crossref
Liangxiao Wang, Shengnan Tang, Yawen Yu, Yanan Lv, Aiping Wang, Xiuju Yan, Nuannuan Li, Chunjie Sha, Kaoxiang Sun & Youxin Li. (2021) Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting. Molecular Pharmaceutics 18:3, pages 915-927.
Crossref
Ying Qu, Ang Li, Long Ma, Sajid Iqbal, Xiao Sun, Wenqing Ma, Chunyan Li, Dandan Zheng, Zixuan Xu, Zhongxi Zhao & Dedong Ma. (2021) Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy. International Journal of Pharmaceutics 597, pages 120250.
Crossref
Anna Froelich, Tomasz Osmałek, Barbara Jadach, Vinam Puri & Bozena Michniak-Kohn. (2021) Microemulsion-Based Media in Nose-to-Brain Drug Delivery. Pharmaceutics 13:2, pages 201.
Crossref
Tatyana Alexandrovna Bogoyavlenskaya, Ekaterina Evgenyevna Tyagunova, Roman Konstantinovich Kostin, Alexander Sergeevich Zaharov, Yuriy Leonidovich Vasil'ev & Olesya Vasilevna Kytko. (2021) Glioblastoma Break-in; Try Something New. International Journal of Cancer Management 14:1.
Crossref
Mukta Agrawal, Aditya Narayan Konwar, Amit Alexander & Vivek Borse. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery 305 328 .
Rahul Shukla, Ashish Kumar & S.J.S. Flora. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery 73 91 .
Sunita Lahkar & Malay K. Das. 2021. Multifunctional Theranostic Nanomedicines in Cancer. Multifunctional Theranostic Nanomedicines in Cancer 115 146 .
Lynn Jena, Nicholas J. Dunne & Helen O. McCarthy. 2021. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies 707 747 .
A. A. Navas, N. Doreswamy & P. J. Joseph Francis. (2020) Nanomedicine and Immunotherapy for Cancers. European Journal of Medical and Health Sciences 2:5.
Crossref
Mingchao Wang, Jian Chen, Wenjun Li, Fan Zang, Xuexia Liu & Song Qin. (2020) Paclitaxel-nanoparticles-loaded double network hydrogel for local treatment of breast cancer after surgical resection. Materials Science and Engineering: C 114, pages 111046.
Crossref
Prashant G. Upadhaya, Sreeranjini Pulakkat & Vandana B. Patravale. (2020) Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management. Drug Delivery and Translational Research 10:4, pages 1044-1056.
Crossref
Robert M. Hughes & Jitka A.I. Virag. (2020) Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications. Pharmaceuticals 13:6, pages 112.
Crossref
Peter W. Janes, Mary E. Vail, Hui K. Gan & Andrew M. Scott. (2020) Antibody Targeting of Eph Receptors in Cancer. Pharmaceuticals 13:5, pages 88.
Crossref
Agnieszka Belter, Jakub Barciszewski & Anna-Maria Barciszewska. (2020) Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions. PLOS ONE 15:2, pages e0229534.
Crossref
Shahryar Shakeri, Milad Ashrafizadeh, Ali Zarrabi, Rasoul Roghanian, Elham Ghasemipour Afshar, Abbas Pardakhty, Reza Mohammadinejad, Anuj Kumar & Vijay Kumar Thakur. (2020) Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics. Biomedicines 8:1, pages 13.
Crossref
Yingying Zhang, Chen Chen, Jinghui Zhao & Guiyan Liu. (2019) Rhodium‐Catalyzed Cascade Radical Cyclization of 1,6‐Enynes with Br−CX 3 : Access to Bromine‐Containing Trihalomethylated Pyrrolidines . Asian Journal of Organic Chemistry 8:12, pages 2249-2256.
Crossref
Franciele Aline Bruinsmann, Gustavo Richter Vaz, Aline de Cristo Soares Alves, Tanira Aguirre, Adriana Raffin Pohlmann, Silvia Stanisçuaski Guterres & Fabio Sonvico. (2019) Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials. Molecules 24:23, pages 4312.
Crossref
Lucia Salvioni, Maria Antonietta Rizzuto, Jessica Armida Bertolini, Laura Pandolfi, Miriam Colombo & Davide Prosperi. (2019) Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope. Cancers 11:12, pages 1855.
Crossref
Qiongli Su, Shengping Luo, Qiuhong Tan, Jun Deng, Sichun Zhou, Mei Peng, Ting Tao & Xiaoping Yang. (2019) The role of pyruvate kinase M2 in anticancer therapeutic treatments (Review). Oncology Letters.
Crossref
Tingwang Guo, Yuanyuan Guo, Yuhua Gong, Jingou Ji, Shilei Hao, Jia Deng & Bochu Wang. (2019) An enhanced charge-driven intranasal delivery of nicardipine attenuates brain injury after intracerebral hemorrhage. International Journal of Pharmaceutics 566, pages 46-56.
Crossref
Chunyan Zhang, Aiping Wang, Huiyun Wang, Maocai Yan, Rongcai Liang, Xiuting He, Fenghua Fu, Hongjie Mu & Kaoxiang Sun. (2019) Entecavir-loaded poly (lactic-co-glycolic acid) microspheres for long-term therapy of chronic hepatitis-B: Preparation and in vitro and in vivo evaluation. International Journal of Pharmaceutics 560, pages 27-34.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.